Skip to main content
Top
Published in: Current Hypertension Reports 10/2014

01-10-2014 | Preeclampsia (VD Garovic, Section Editor)

Hypertensive Pregnancy Disorders and Future Renal Disease

Authors: Steven Wagner, Iasmina Craici

Published in: Current Hypertension Reports | Issue 10/2014

Login to get access

Abstract

Hypertensive pregnancy disorders affect approximately 6 to 8 % of otherwise normal pregnancies. A growing body of evidence links these disorders with the future development of hypertension, coronary disease, cerebrovascular disease, and peripheral arterial disease. Larger studies associating hypertensive pregnancy to future development of renal disease have been lacking until recently, with publication of several compelling studies in the last 5 years. In this review, we will focus on the recent evidence associating hypertensive pregnancy disorders with the future development of chronic kidney disease (CKD) and end-stage renal disease (ESRD), as well as the development of microalbuminuria. We will also attempt to answer whether these renal risks are due to direct effects of hypertension during pregnancy, or whether they are due to shared environmental and genetic risk factors.
Literature
3.
go back to reference Rochat RW, Koonin LM, Atrash HK, Jewett JF. Maternal mortality in the United States: report from the Maternal Mortality Collaborative. Obstet Gynecol. 1988;72(1):91–7.PubMed Rochat RW, Koonin LM, Atrash HK, Jewett JF. Maternal mortality in the United States: report from the Maternal Mortality Collaborative. Obstet Gynecol. 1988;72(1):91–7.PubMed
5.
go back to reference Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982;1(8287):1430–2.PubMedCrossRef Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982;1(8287):1430–2.PubMedCrossRef
7.
go back to reference Bar J, Kaplan B, Wittenberg C, Erman A, Boner G, Ben-Rafael Z, et al. Microalbuminuria after pregnancy complicated by pre-eclampsia. Nephrol, Dials, Transplant: Off Publ Eur Dial Transplant Assoc - Eur Renal Assoc. 1999;14(5):1129–32.CrossRef Bar J, Kaplan B, Wittenberg C, Erman A, Boner G, Ben-Rafael Z, et al. Microalbuminuria after pregnancy complicated by pre-eclampsia. Nephrol, Dials, Transplant: Off Publ Eur Dial Transplant Assoc - Eur Renal Assoc. 1999;14(5):1129–32.CrossRef
8.
go back to reference Nisell H, Lintu H, Lunell NO, Mollerstrom G, Pettersson E. Blood pressure and renal function seven years after pregnancy complicated by hypertension. Br J Obstet Gynaecol. 1995;102(11):876–81.PubMedCrossRef Nisell H, Lintu H, Lunell NO, Mollerstrom G, Pettersson E. Blood pressure and renal function seven years after pregnancy complicated by hypertension. Br J Obstet Gynaecol. 1995;102(11):876–81.PubMedCrossRef
9.•
go back to reference McDonald SD, Han Z, Walsh MW, Gerstein HC, Devereaux PJ. Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis: Off J Nat Kidney Found. 2010;55(6):1026–39. doi:10.1053/j.ajkd.2009.12.036. The first systematic meta-analysis of smaller studies examining the risk of future microalbuminuria after a preeclamptic pregnancy found that risk was increased 4- to 8-fold for preeclampsia and severe preeclampsia, respectively.CrossRef McDonald SD, Han Z, Walsh MW, Gerstein HC, Devereaux PJ. Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis: Off J Nat Kidney Found. 2010;55(6):1026–39. doi:10.​1053/​j.​ajkd.​2009.​12.​036. The first systematic meta-analysis of smaller studies examining the risk of future microalbuminuria after a preeclamptic pregnancy found that risk was increased 4- to 8-fold for preeclampsia and severe preeclampsia, respectively.CrossRef
10.•
go back to reference Sandvik MK, Hallan S, Svarstad E, Vikse BE. Preeclampsia and prevalence of microalbuminuria 10 years later. Clin J Am Soc Nephrol: CJASN. 2013;8(7):1126–34. doi:10.2215/CJN.10641012. Examined 89 women with preeclampsia 9–11 years after delivery, compared to 69 normotensive controls. Did not find any difference in albumin excretion between the two groups, although the study might have been underpowered.PubMedCrossRefPubMedCentral Sandvik MK, Hallan S, Svarstad E, Vikse BE. Preeclampsia and prevalence of microalbuminuria 10 years later. Clin J Am Soc Nephrol: CJASN. 2013;8(7):1126–34. doi:10.​2215/​CJN.​10641012. Examined 89 women with preeclampsia 9–11 years after delivery, compared to 69 normotensive controls. Did not find any difference in albumin excretion between the two groups, although the study might have been underpowered.PubMedCrossRefPubMedCentral
11.•
go back to reference Kattah AG, Asad R, Scantlebury DC, Bailey KR, Wiste HJ, Hunt SC, et al. Hypertension in pregnancy is a risk factor for microalbuminuria later in life. J Clin Hypertens. 2013;15(9):617–23. doi:10.1111/jch.12116. Examined a large group of 475 women with a history of preeclampsia compared with 2,199 controls. Found a significantly increased risk of microalbuminuria (OR = 1.37).CrossRef Kattah AG, Asad R, Scantlebury DC, Bailey KR, Wiste HJ, Hunt SC, et al. Hypertension in pregnancy is a risk factor for microalbuminuria later in life. J Clin Hypertens. 2013;15(9):617–23. doi:10.​1111/​jch.​12116. Examined a large group of 475 women with a history of preeclampsia compared with 2,199 controls. Found a significantly increased risk of microalbuminuria (OR = 1.37).CrossRef
12.•
go back to reference Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med. 2008;359(8):800–9. doi:10.1056/NEJMoa0706790. One of the first studies to convincingly show an association between past preeclamptic pregnancy and ESRD.PubMedCrossRef Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med. 2008;359(8):800–9. doi:10.​1056/​NEJMoa0706790. One of the first studies to convincingly show an association between past preeclamptic pregnancy and ESRD.PubMedCrossRef
13.•
go back to reference Wang IK, Muo CH, Chang YC, Liang CC, Chang CT, Lin SY, et al. Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study. CMAJ: Can Med Assoc J = J l'Assoc Med Can. 2013;185(3):207–13. doi:10.1503/cmaj.120230. A study of insurance claim data comparing 26,651 preeclamptic women to 213,397 normotensive controls. The hazard ratio for ESRD was above 12, but fell to 2.72 after controlling for hypertension and diabetes at follow-up.CrossRef Wang IK, Muo CH, Chang YC, Liang CC, Chang CT, Lin SY, et al. Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study. CMAJ: Can Med Assoc J = J l'Assoc Med Can. 2013;185(3):207–13. doi:10.​1503/​cmaj.​120230. A study of insurance claim data comparing 26,651 preeclamptic women to 213,397 normotensive controls. The hazard ratio for ESRD was above 12, but fell to 2.72 after controlling for hypertension and diabetes at follow-up.CrossRef
14.•
go back to reference Wu CC, Chen SH, Ho CH, Liang FW, Chu CC, Wang HY, et al. End-stage renal disease after hypertensive disorders in pregnancy. Am J Obstet Gynecol. 2014;210(2):147–e1-8. doi:10.1016/j.ajog.2013.09.027. Similar to Wang et al. in that the authors examined insurance claim data. Found a 10-fold increase in the incidence of ESRD after preeclamptic pregnancy but, again, was not able to convincingly control for confounding medical conditions.PubMedCrossRef Wu CC, Chen SH, Ho CH, Liang FW, Chu CC, Wang HY, et al. End-stage renal disease after hypertensive disorders in pregnancy. Am J Obstet Gynecol. 2014;210(2):147–e1-8. doi:10.​1016/​j.​ajog.​2013.​09.​027. Similar to Wang et al. in that the authors examined insurance claim data. Found a 10-fold increase in the incidence of ESRD after preeclamptic pregnancy but, again, was not able to convincingly control for confounding medical conditions.PubMedCrossRef
16.
go back to reference Aita K, Etoh M, Hamada H, Yokoyama C, Takahashi A, Suzuki T, et al. Acute and transient podocyte loss and proteinuria in preeclampsia. Nephron Clin Pract. 2009;112(2):c65–70. doi:10.1159/000213083.PubMedCrossRef Aita K, Etoh M, Hamada H, Yokoyama C, Takahashi A, Suzuki T, et al. Acute and transient podocyte loss and proteinuria in preeclampsia. Nephron Clin Pract. 2009;112(2):c65–70. doi:10.​1159/​000213083.PubMedCrossRef
17.
go back to reference Zhao S, Gu Y, Coates G, Groome LJ, Saleem MA, Mathieson PW, et al. Altered nephrin and podoplanin distribution is associated with disturbed polarity protein PARD-3 and PARD-6 expressions in podocytes from preeclampsia. Reprod Sci. 2011;18(8):772–80. doi:10.1177/1933719111398145.PubMedCrossRef Zhao S, Gu Y, Coates G, Groome LJ, Saleem MA, Mathieson PW, et al. Altered nephrin and podoplanin distribution is associated with disturbed polarity protein PARD-3 and PARD-6 expressions in podocytes from preeclampsia. Reprod Sci. 2011;18(8):772–80. doi:10.​1177/​1933719111398145​.PubMedCrossRef
19.
go back to reference Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol: JASN. 2005;16(10):2941–52. doi:10.1681/ASN.2005010055.PubMedCrossRef Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol: JASN. 2005;16(10):2941–52. doi:10.​1681/​ASN.​2005010055.PubMedCrossRef
21.•
go back to reference Davis EF, Lazdam M, Lewandowski AJ, Worton SA, Kelly B, Kenworthy Y, et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics. 2012;129(6):e1552–61. doi:10.1542/peds.2011-3093. A concise review of an important topic, highlighting the various cardiovascular risks that are associated with being born of a preeclamptic pregnancy.PubMedCrossRef Davis EF, Lazdam M, Lewandowski AJ, Worton SA, Kelly B, Kenworthy Y, et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics. 2012;129(6):e1552–61. doi:10.​1542/​peds.​2011-3093. A concise review of an important topic, highlighting the various cardiovascular risks that are associated with being born of a preeclamptic pregnancy.PubMedCrossRef
22.
go back to reference White SL, Perkovic V, Cass A, Chang CL, Poulter NR, Spector T, et al. Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis: Off J Nat Kidney Found. 2009;54(2):248–61. doi:10.1053/j.ajkd.2008.12.042.CrossRef White SL, Perkovic V, Cass A, Chang CL, Poulter NR, Spector T, et al. Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis: Off J Nat Kidney Found. 2009;54(2):248–61. doi:10.​1053/​j.​ajkd.​2008.​12.​042.CrossRef
23.
go back to reference Hack M, Schluchter M, Cartar L, Rahman M. Blood pressure among very low birth weight (<1.5 kg) young adults. Pediatr Res. 2005;58(4):677–84.PubMedCrossRef Hack M, Schluchter M, Cartar L, Rahman M. Blood pressure among very low birth weight (<1.5 kg) young adults. Pediatr Res. 2005;58(4):677–84.PubMedCrossRef
24.
go back to reference Rotteveel J, van Weissenbruch MM, Twisk JW, Delemarre-Van de Waal HA. Infant and childhood growth patterns, insulin sensitivity, and blood pressure in prematurely born young adults. Pediatrics. 2008;122(2):313–21.PubMedCrossRef Rotteveel J, van Weissenbruch MM, Twisk JW, Delemarre-Van de Waal HA. Infant and childhood growth patterns, insulin sensitivity, and blood pressure in prematurely born young adults. Pediatrics. 2008;122(2):313–21.PubMedCrossRef
25.
27.
go back to reference Sullivan A KS, Joshi H. Social class and inequalities in early cognitive scores. Sociology. 2013;47(6). Sullivan A KS, Joshi H. Social class and inequalities in early cognitive scores. Sociology. 2013;47(6).
28.
go back to reference Gordin D, Hiilesmaa V, Fagerudd J, Ronnback M, Forsblom C, Kaaja R, et al. Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women. Diabetologia. 2007;50(3):516–22. doi:10.1007/s00125-006-0544-5.PubMedCrossRef Gordin D, Hiilesmaa V, Fagerudd J, Ronnback M, Forsblom C, Kaaja R, et al. Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women. Diabetologia. 2007;50(3):516–22. doi:10.​1007/​s00125-006-0544-5.PubMedCrossRef
29.
go back to reference Jacquemyn Y, Jochems L, Duiker E, Bosmans JL, Van Hoof V, Van Campenhout C. Long-term renal function after HELLP syndrome. Gynecol Obstet Investig. 2004;57(2):117–20. doi:10.1159/000075942.CrossRef Jacquemyn Y, Jochems L, Duiker E, Bosmans JL, Van Hoof V, Van Campenhout C. Long-term renal function after HELLP syndrome. Gynecol Obstet Investig. 2004;57(2):117–20. doi:10.​1159/​000075942.CrossRef
31.
go back to reference North RA, Simmons D, Barnfather D, Upjohn M. What happens to women with preeclampsia? Microalbuminuria and hypertension following preeclampsia. Aust N Z J Obstet Gynaecol. 1996;36(3):233–8.PubMedCrossRef North RA, Simmons D, Barnfather D, Upjohn M. What happens to women with preeclampsia? Microalbuminuria and hypertension following preeclampsia. Aust N Z J Obstet Gynaecol. 1996;36(3):233–8.PubMedCrossRef
32.
go back to reference Shammas AG, Maayah JF. Hypertension and its relation to renal function 10 years after pregnancy complicated by pre-eclampsia and pregnancy induced hypertension. Saudi Med J. 2000;21(2):190–2.PubMed Shammas AG, Maayah JF. Hypertension and its relation to renal function 10 years after pregnancy complicated by pre-eclampsia and pregnancy induced hypertension. Saudi Med J. 2000;21(2):190–2.PubMed
Metadata
Title
Hypertensive Pregnancy Disorders and Future Renal Disease
Authors
Steven Wagner
Iasmina Craici
Publication date
01-10-2014
Publisher
Springer US
Published in
Current Hypertension Reports / Issue 10/2014
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-014-0484-2

Other articles of this Issue 10/2014

Current Hypertension Reports 10/2014 Go to the issue

Secondary Hypertension: Nervous System Mechanisms (J Bisognano, Section Editor)

Anxiety in the “Age of Hypertension”

Resistant Hypertension (E Pimenta, Section Editor)

Resistant or Refractory Hypertension: Are They Different?

Pathogenesis of Hypertension (W Elliott, Section Editor)

Obstructive Sleep Apnea and Hypertension: a Critical Review

Blood Pressure Monitoring and Management (G Ogedegbe and JA Staessen, Section Editors)

Psychosocial Risk Factors for Hypertension: an Update of the Literature

Blood Pressure Monitoring and Management (G Ogedegbe and JA Staessen, Section Editors)

Out-of-Office Blood Pressure Improves Risk Stratification in Normotension and Prehypertension People

Prevention of Hypertension: Public Health Challenges (P Muntner, Section Editor)

Ambulatory Blood Pressure Phenotypes and the Risk for Hypertension

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.